Clinical Trials Directory

Trials / Completed

CompletedNCT00184353

Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.

In Vivo Proton MR Spectroscopy of Brain Metastases Obtained at 1,5T and 3T.

Status
Completed
Phase
Study type
Observational
Enrollment
19 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Increasing magnetic field is known to give improvements in signal-to-noise-ratio (SNR) and spectral resolution. To investigate this, spectra from different subjects were examined using two clinical MR instruments operating at 1.5T and 3T respectively.

Conditions

Timeline

Start date
2003-11-01
Primary completion
2004-12-01
Completion
2005-06-01
First posted
2005-09-16
Last updated
2011-10-21

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00184353. Inclusion in this directory is not an endorsement.

Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T. (NCT00184353) · Clinical Trials Directory